throbber
Chapter 5 Amino Acids, Peptides, and Proteins
`
`157
`
`15. Sequence Determination of the Brain Pep-
`tide Leucine Enkephalin A group of peptides that
`influence nerve transmission in certain parts of the
`brain has been isolated from normal brain tissue.
`
`These peptides are knownas opioids, because they
`bind to specific receptors that also bind opiate drugs,
`such as morphine and naloxone. Opioids thus mimic
`some of the properties of opiates. Some researchers
`consider these peptides to be the brain’s own pain
`killers. Using the information below, determine the
`amino acid sequence ofthe opioid leucine enkephalin.
`Explain how your structure is consistent with each
`piece of information.
`
`(a) Complete hydrolysis by 6 M HCl at 110 °C fol-
`lowed by amino acid analysis indicated the presence of
`Gly, Leu, Phe, and Tyr, in a 2:1:1:1 molarratio.
`
`(b) Treatment of the peptide with 1-fluoro-2,4-
`dinitrobenzene followed by complete hydrolysis and
`chromatography indicated the presence of the 2,4-
`dinitrophenyl derivative of tyrosine. No free tyrosine
`could be found.
`
`(c) Complete digestion of the peptide with pepsin
`followed by chromatography yielded a dipeptide con-
`taining Phe and Leu, plus a tripeptide containing Tyr
`and Gly in a 1:2 ratio.
`
`16. Structure of a Peptide Antibiotic from Bacil-
`lus brevis Extracts from the bacterium Bacillus
`
`brevis contain a peptide with antibiotic properties.
`This peptide forms complexes with metal ions and
`apparently disrupts ion transport across the cell
`membranes of other bacterial species, killing them. The
`structure of the peptide has been determined from the
`following observations.
`
`(a) Complete acid hydrolysis of the peptide fol-
`lowed by amino acid analysis yielded equimolar
`amounts of Leu, Orn, Phe, Pro, and Val. Ornis or-
`nithine, an amino acid not present in proteins but pre-
`sent in some peptides. It has the structure
`
`H
`*
`|
`H,N—CH,—CH,—CH,—C—COO-
`*NH,
`
`(b) The molecular weightof the peptide was esti-
`mated as about 1,200.
`
`(c) The peptide failed to undergo hydrolysis when
`treated with the enzyme carboxypeptidase. This en-
`zyme catalyzes the hydrolysis of the carboxyl-terminal
`residue of a polypeptide unless the residue is Pro or
`does not contain a free carboxyl group for some rea-
`son.
`
`(d) Treatment of the intact peptide with 1-fluoro-
`2,4-dinitrobenzene, followed by complete hydrolysis
`and chromatography, yielded only free amino acids
`and the following derivative:
`
`O,N
`
`i
`NO,
`NH—CH,—CH,—CH,—C—COO-
`*NH,
`
`(Hint: Note that the 2,4-dinitrophenyl derivative in-
`volves the amino groupof a side chain rather than the
`qa-amino group.)
`
`(e) Partial hydrolysis of the peptide followed by
`chromatographic separation and sequence analysis
`yielded the following di- and tripeptides (the amino-
`terminal aminoacid is always at theleft):
`
`Leu—Phe Phe-Pro Orn-Leu Val—Orn
`Val—Orn—Leu Phe—Pro-Val
`Pro—Val—Orn
`
`Given the above information, deduce the amino acid
`sequence of the peptide antibiotic. Show your reason-
`ing. When you have arrived at a structure, demon-
`strate that it is consistent with each experimental ob-
`servation.
`
`17. Efficiency in Peptide Sequencing A peptide
`with the primary structure Lys—Arg—Pro—Leu—Ile—
`Asp—Gly—Ala is sequenced by the Edman procedure.
`If each Edman cycle were 96% efficient, what per-
`centage of the amino acids liberated in the fourth cy-
`cle would be leucine? Do the calculation a second
`time, but assume a 99% efficiency for each cycle.
`
`18. Biochemistry Protocols: Your First Protein
`Purification As the newest and least experienced
`student in a biochemistry research lab, your first few
`weeks are spent washing glassware and labeling test
`tubes. You then graduate to making buffers and stock
`solutions for use in various laboratory procedures. Fi-
`nally, you are given responsibility for purifying a pro-
`tein. It is a citric acid cycle enzyme, citrate synthase,
`located in the mitochondrial matrix. Following a pro-
`tocol for the purification, you proceed through the
`steps below. As you work, a more experienced student
`questions you about the rationale for each procedure.
`Supply the answers. (Hint: See Chapter 2 for informa-
`tion on separation of organelles from cells, and Chap-
`ter 4 for information about osmolarity).
`
`(a) You pick up 20 kg of beef hearts from a nearby
`slaughterhouse. You transport the hearts on ice, and
`perform each step of the purification in a walk-in cold
`roomor on ice. You homogenize the beef hearttissue
`ina high-speed blender in a medium containing ~0.2 M
`sucrose, buffered to a pH of 7,2. Why do you use beef
`heart tissue, and in such large quantity? What is
`the purpose of keeping the tissue cold and sus-
`pending it in 0.2 mM sucrose, at pH 7.2? What hap-
`pens to the tissue when it is homogenized?
`
`MSN Exhibit 1012 - Part 3 - Page 1 of 24
`MSNv. Bausch - IPR2023-00016
`
`MSN Exhibit 1012 - Part 3 - Page 1 of 24
`MSN v. Bausch - IPR2023-00016
`
`

`

`
`
`Protein Function
`
`Knowing the three-dimensional structure of a protein is an important part
`of understanding how the protein functions. However, the structure shown
`in two dimensions on a pageis deceptively static. Proteins are dynamic mol-
`ecules whose functions almost invariably depend on interactions with other
`molecules, and these interactions are affected in physiologically important
`ways by sometimes subtle, sometimes striking changes in protein confor-
`mation.
`In this chapter, we explore how proteins interact with other molecules
`and how their interactions are related to dynamic protein structure. The im-
`portance of molecular interactions to a protein’s function can hardly be
`overemphasized. In Chapter 6, we saw that the function of fibrous proteins
`as structural elements of cells and tissues depends on stable, long-term
`quaternary interactions between identical polypeptide chains. As we will
`see in this chapter, the functions of many other proteins involve interac-
`tions with a variety of different molecules. Most of these interactions are
`fleeting, though they may be the basis of complex physiological processes
`such as oxygen transport, immune function, and muscle contraction, the
`topics we examine in detail in this chapter. The proteins that carry out
`these processesillustrate the following key principles of protein function,
`some of which will be familiar from the previous chapter:
`
`The functions of many proteins involve the reversible binding of other
`molecules. A molecule bound reversibly by a protein is called a ligand.
`A ligand may be any kind of molecule, including another protein. The
`transient nature of protein-ligand interactionsis critical to life, allowing
`an organism to respond rapidly and reversibly to changing environ-
`mental and metabolic circumstances.
`
`A ligand bindsat a site on the protein called the binding site, which
`is complementary to the ligand in size, shape, charge, and hydropho-
`bic or hydrophilic character. Furthermore, the interaction is specific:
`the protein can discriminate among the thousandsofdifferent mole-
`cules in its environment and selectively bind only one or a few. A
`given protein may have separate binding sites for several different lig-
`ands. These specific molecular interactions are crucial in maintaining
`the high degree oforderin a living system. (This discussion excludes
`the binding of water, which may interact weakly and nonspecifically
`with many parts of a protein. In Chapter 8, we consider water as a
`specific ligand for many enzymes.)
`
`Proteins are flexible. Changes in conformation may be subtle, reflect-
`ing molecular vibrations and small movements of amino acid residues
`MSN Exhibit 1012 - Part 3 - Page 2 of 24
`MSN Exhibit 1012 - Part 3 - Page 2 of 24
`MSN v. Bausch - IPR2023-00016
`MSNv. Bausch - IPR2023-00016 °°
`
`

`

`204
`
`Part Il Structure and Catalysis
`
`throughout the protein. A protein flexing in this way is sometimes said
`to “breathe.” Changes in conformation may also be quite dramatic,
`with major segments of the protein structure moving as much as sev-
`eral nanometers. Specific conformational changes are frequently es-
`sential to a protein’s function.
`
`The binding of a protein and ligandis often coupled to a conforma-
`tional changein the protein that makes the binding site more comple-
`mentary to the ligand, permitting tighter binding. The structural adap-
`tation that occurs between protein andligandis called inducedfit.
`
`In a multisubunit protein, a conformational change in one subunit
`often affects the conformation of other subunits.
`
`Interactions between ligands and proteins may be regulated, usually
`through specific interactions with one or more additionalligands.
`These other ligands may cause conformational changesin the protein
`that affect the binding of the first ligand.
`
`Enzymes represent a special case of protein function. Enzymes bind
`and chemically transform other molecules—theycatalyze reactions. The
`molecules acted upon by enzymes are called reaction substrates rather
`than ligands, and the ligand-binding site is called the catalytic site or
`active site. In this chapter we emphasize the noncatalytic functions of pro-
`teins. In Chapter 8 we consider catalysis by enzymes, a central topic in bio-
`chemistry. You will see that the themesof this chapter—binding,specificity,
`and conformational change—are continued in the next chapter, with the
`added elementof proteins acting as reactants in chemical transformations.
`
`Reversible Binding of a Protein to a Ligand:
`Oxygen-Binding Proteins
`Myoglobin and hemoglobin may be the most-studied and best-understood
`proteins. They were the first proteins for which three-dimensional struc-
`tures were determined, and our current understanding of myoglobin and
`hemoglobin is garnered from the work of thousands of biochemists over
`several decades. Most important, theyillustrate almost every aspectof that
`most central of biochemical processes: the reversible binding ofa ligand to
`a protein. This classic model of protein function will tell us a great. deal
`about howproteins work.
`
`Oxygen Can Be Bound to a HemeProsthetic Group
`Oxygenis poorly soluble in aqueoussolutions (see Table 4-3) and cannot be
`carried to tissues in sufficient quantity if it is simply dissolved in blood serum.
`Diffusion of oxygen through tissuesis also ineffective over distances greater
`than a few millimeters. The evolutionof larger, multicellular animals depended
`on the evolution of proteins that could transport and store oxygen. How-
`ever, none of the amino acidside chains in proteins is suited for the revers-
`ible binding of oxygen molecules. This role is filed by certain transition met-
`als, among them iron and copper, that have a strong tendency to bind oxygen.
`Multicellular organisms exploit the properties of metals, most commonlyiron,
`for oxygen transport. However, free iron promotes the formation of highly
`reactive oxygen species such as hydroxyl radicals that can damage DNA
`and other macromolecules. Iron used in cells is therefore bound in forms
`that sequester it and/or makeit less reactive. In multicellular organisms—
`especially those in which iron, in its oxygen-carrying capacity, must be
`transported overlarge distances—ironis often incorporated into a protein-
`boundprosthetic group called heme.(A prosthetic group is a compoundper-
`manently associated with a protein that contributes to the protein's function.)
`MSN Exhibit 1012 - Part 3 - Page 3 of 24
`MSN Exhibit 1012 - Part 3 - Page 3 of 24
`MSN v. Bausch - IPR2023-00016
`MSNv. Bausch - IPR2023-00016
`
`

`

`Chapter 7 Protein Function
`
`205
`
`figure 7-1
`Heme. The heme group is present in myoglobin, hemo-
`globin, and many other proteins, designated heme pro-
`teins. Hemeconsists of a complex organic ring structure,
`protoporphyrin IX, to which is bound an iron atom in its
`ferrous (Fe**) state. Porphyrins, of which protoporphyrin
`IX is only one example, consist of four pyrrole rings linked
`by methene bridges (a), with substitutions at one or more
`of the positions denoted X. Two representations of heme
`are shownin (b) and (c). The iron atom of heme has six
`coordination bonds: four in the plane of, and bonded
`to, the flat porphyrin ring system, and two perpendicular
`to it (d).
`
`xX
`
`xX
`
`xX
`
`x
`
`x
`
`bi
`
`(a)
`
`x
`
`xX
`
`oO
`
`O-
`
`Heme (or haem) consists of a complex organic ring structure, proto-
`porphyrin, to which is bounda single iron atominits ferrous (Fe’*) state
`(Fig. 7-1). The iron atom has six coordination bonds, four to nitrogen
`atoms that are part of the flat porphyrin ring system and two perpendic-
`ular to the porphyrin. The coordinated nitrogen atoms (which have an
`electron-donating character) help prevent conversion of the heme iron to
`the ferric (Fe®*) state. Iron in the Fe** state binds oxygenreversibly; in the
`Fe?* state it does not bind oxygen. Hemeis found in a numberof oxygen-
`transporting proteins, as well as in some proteins, such as the cytochromes,
`that participate in oxidation-reduction (electron transfer) reactions (Chap-
`ter 19).
`In free heme molecules, reaction of oxygen at one of the two “open” co-
`ordination bonds of iron (perpendicular to the plane of the porphyrin mol-
`ecule, above and below) canresult in irreversible conversion of Fe** to
`Fe**. In heme-containing proteins, this reaction is prevented by sequester-
`ing the heme deepwithin a protein structure where access to the two open
`coordination bondsis restricted. One of these two coordination bondsis oc-
`cupied by a side-chain nitrogen of a His residue. The other is the binding
`site for molecular oxygen (O.) (Fig. 7-2). When oxygen binds, the elec-
`tronic properties of hemeiron change; this accounts for the changein color
`from the dark purple of oxygen-depleted venous blood to the bright red of
`oxygen-rich arterial blood. Some small molecules, such as carbon monoxide
`(CO) and nitric oxide (NO), coordinate to heme iron with greater affinity
`than does O.. When a molecule of CO is bound to heme, Og is excluded,
`which is why COis highly toxic to aerobic organisms. By surrounding and
`sequestering heme, oxygen-binding proteins regulate the access of CO and
`other small molecules to hemeiron.
`
`
`
`MSN Exhibit 1012 - Part 3 - Page 4 of 24
`MSN Exhibit 1012 - Part 3 - Page 4 of 24
`MSN v. Bausch - IPR2023-00016
`MSNv. Bausch - IPR2023-00016
`
`Histidine
`residue
`
`Plane of
`porphyrin
`ring system
`
`N
`fi
`Pie
`CH
`ie
`eet
`C
`C
`PEO Fo Bee OS
`cH,-c
`~o
`‘c—cH,
`‘Cc
`K
`Il.
`¥ df
`gee, oe
`CH
`Feo
`oH
`C—N
`*N=C
`cH |
`\o_cH
`|
`CH,

`CH,
`
`CH
`

`CHS
`CH,
`
`(b)
`
`(c)
`
`figure 7-2
`The heme group viewed from the side. This view shows
`the two coordination bonds to Fe** perpendicular to the
`porphyrin ring system. Oneof these two bondsis occu-
`pied by a His residue, sometimes called the proximal His.
`The other is the bindingsite for oxygen. The remaining
`four coordination bonds are in the plane of, and bonded
`to, the flat porphyrin ring system.
`
`
`
`

`

`206
`
`Part ||
`
`Structure and Catalysis
`
`Myoglobin Has a Single Binding Site for Oxygen
`Myoglobin (M/, 16,700; abbreviated Mb)
`is a relatively simple oxygen-
`binding protein found in almost all mammals, primarily in muscle tissue. It
`is particularly abundantin the muscles of diving mammals such as seals and
`whales that must store enough oxygen for prolonged excursions undersea.
`Proteins very similar to myoglobin are widelydistributed, occurring evenin
`some single-celled organisms. Myoglobin stores oxygen for periods when
`energy demandsare high and facilitates its distribution to oxygen-starved
`tissues.
`
`Myoglobin is a single polypeptide of 153 aminoacid residues with one
`molecule of heme. It is typical of the family of proteins called globins,
`which havesimilar primary andtertiary structures. The polypeptide is made
`up of eight a-helical segments connected by bends (Fig. 7-3). About 78%
`of the amino acid residues in the protein are foundin these o helices.
`Any detailed discussion of protein function inevitably involves protein
`structure. Our treatment of myoglobin will be facilitated by introducing
`some structural conventions peculiar to globins. As seen in Figure 7-3, the
`helical segments are labeled A through H. An individual amino acid residue
`may be designated either by its position in the amino acid sequence or by
`its location within the sequence of a particular a-helical segment. For ex-
`ample, the His residue coordinated to the heme in myoglobin, His” (the
`93rd amino acid residue from the amino-terminal end of the myoglobin
`polypeptide sequence), is also called His F8 (the 8th residue in @ helix F).
`The bendsin the structure are labeled AB, CD, EF, and so forth, reflecting
`the a-helical segments they connect.
`
`Protein-Ligand Interactions Can Be Described Quantitatively
`The function of myoglobin depends on the protein’s ability not only to bind
`oxygen, but also to release it when and whereit is needed. Function in bio-
`chemistry often revolves around a reversible protein-ligand interaction of
`this type. A quantitative description of this interaction is therefore a central
`part of many biochemical investigations.
`
`
`
`figure 7-3
`The structure of myoglobin. The eight a-helical seg-
`ments (shown here as cylinders) are labeled A through H.
`Nonhelical residues in the bends that connect them are
`labeled AB, CD, EF, and so forth, indicating the segments
`they interconnect. A few bends, including BC and DE,are
`abrupt and do not contain any residues; these are not
`normally labeled. (The short segmentvisible between D
`andEis an artifact of the computer representation.) The
`hemeis bound in a pocket made up largely of the E and
`F helices, although amino acid residues from other seg-
`ments of the protein also participate.
`
`MSN Exhibit 1012 - Part 3 - Page 5 of 24
`MSN Exhibit 1012 - Part 3 - Page 5 of 24
`MSN v. Bausch - IPR2023-00016
`MSNv. Bausch - IPR2023-00016
`
`

`

`Chapter 7 Protein Function
`
`207
`
`In general, the reversible binding of a protein (P) to a ligand (L) can be
`described by a simple equilibrium expression:
`
`P+L = PL
`
`(7-1)
`
`The reaction is characterized by an equilibrium constant, K,, such that
`
`Lee«> TPL]
`(7-2)
`The term K,is an association constant (not to be confused with the K,
`that denotes an acid dissociation constant; see p. 98). The association con-
`stant provides a measureof the affinity of the ligand L for the protein. K,
`has units of M~!; a higher value of K, correspondsto a higheraffinity of the
`ligand for the protein. A rearrangement of Equation 7-2 showsthat the ra-
`tio of bound to free protein is directly proportional to the concentration of
`free ligand:
`
`(7-3)
`
`[PL]
`(P|
`K,[L]
`Whenthe concentration ofthe ligand is much greater than the concentration
`of ligand-bindingsites, the binding of theligand by the protein does not ap-
`preciably change the concentration of free (unbound) ligand—thatis, [L] re-
`mains constant. This condition is broadly applicable to mostligands that bind
`to proteins in cells and simplifies our description of the binding equilibrium.
`Thus we can consider the binding equilibrium from the standpoint of
`the fraction, @ (theta), of ligand-binding sites on the protein that are occu-
`pied by ligand:
`
`a binding sites occupied ——_[PL]
`total binding sites
`[PL] + [P]
`ie
`Substituting K,[L][P] for [PL] (see Eqn 7-3) and rearranging terms gives
`
`6
`
`K,{LI[P]
`
`KL]
`
`__
`
`[4
`
`figure 7-4
`Graphical representations of ligand binding. The frac-
`| ALP) + OP) KIL) +1 ey Aa
`tion of ligand-binding sites occupied, 6, is plotted against
`the concentration of free ligand. Both curves are rectan-
`gular hyperbolas. (a) A hypothetical binding curvefor a
`The term K, can be determined fromaplot of @ versus the concentration of
`ligand L. The LL] at which half of the available ligand-
`free ligand,
`[L] (Fig. 7-4a). Any equation of the form x = y/(y + 2) de-
`binding sites are occupied is equivalent to 1/K,, or Ky.
`scribes a hyperbola, and 6 is thus found to be a hyperbolic function of [L].
`The curve has a horizontal asymptote at @ = 1 and a ver-
`The fraction of ligand-binding sites occupied approaches saturation asymp-
`tical asymptote (not shown) at [L] = —1/K,. (b) A curve
`describing the binding of oxygen to myoglobin. The partial
`totically as [L] increases. The[L] at which half of the available ligand-bind-
`pressure of O, in the air above the solution is expressed
`ing sites are occupied (at @ = 0.5) correspondsto 1/K,.
`in terms of kilopascals (kPa). Oxygen binds tightly to myo-
`globin with a Pep of only 0.26 kPa.
`
`(7-5)
`
`
`
`Ki
`
`5
`({L] (arbitrary units)
`(a)
`
`10
`
`
`
`MSN Exhibit 1012 - Part 3 - Page 6 of 24
`MSN Exhibit 1012 - Part 3 - Page 6 of 24
`MSN v. Bausch - IPR2023-00016
`MSNv. Bausch - IPR2023-00016
`
`1.0
`
`a
`
`5
`pO» (kPa)
`(b)
`
`10
`
`

`

`208
`
`Part Il Structure and Catalysis
`
`It is sometimes intuitively simpler to consider the dissociation con-
`stant, Ky, which is the reciprocal of K, (Ky = 1/K,) andis given in units of
`molar concentration (m). A, is the equilibrium constant for the release of
`ligand. The relevant expressions change to
`
`,-
`[PL] = Ie
`d
`_ (Ly
`(7-8)
`= (L] + K,
`When[L] is equal to K,, half of the ligand-binding sites are occupied.
`When [L] is lower than Ky,little ligand binds to the protein. In order for 90%
`of the available ligand-binding sites to be occupied, [L] must be nine times
`greater than q. In practice, Ay is used much moreoften than K, to express
`the affinity of a protein for a ligand. Note that a lower value of K, corre-
`spondsto a higheraffinity of ligand for the protein. The mathematics can be
`reduced to simple statements: K, is the molar concentration of ligand at
`which half of the available ligand-binding sites are occupied. At this point,
`the protein is said to have reached half saturation with respect to ligand
`binding. The moretightly a protein binds a ligand, the lower the concentra-
`tion of ligand required for half the binding sites to be occupied, and thus the
`lowerthe value of K,. Some representative dissociation constants are given
`in Table 7-1.
`The binding of oxygen to myoglobin follows the patterns discussed
`above, but because oxygenis a gas, we must make some minor adjustments
`to the equations. We can simply substitute the concentration of dissolved
`oxygen for [L] in Equation 7-8 to give
`niug rele
`[02] + Ky
`Asfor any ligand, K, is equal to the [O,] at which half of the available ligand-
`binding sites are occupied, or [O2],;. Equation 7-9 becomes
`
`[O.]
`[92] + [Oz]os
`
`0-8
`(7-7)
`
`(7-9)
`
`(7-10)
`
`=
`
`| SomeProtein Dissociation Constants
`
`| Protein
`Ligand
`Kg ()*
`
`
`| Avidin (egg white)’
`|
`Insulin receptor (human)
`| Anti-HIV immunoglobulin
`|
`(human)?
`| Nickel-binding protein (E. coli)
`1x 10°’
`Calmodulin (rat)$
`3 x 1076
`'
`2x 105
`
`
`
`Biotin
`Insulin
`gp41 (HIV-1 surface
`protein)
`Ni?*
`Gat
`
`1x 10°15
`1.x 107°
`4x 10719
`
`
`
` ARIPOSOLEILEEE RSE SAAR DARRELLRADEEASR ey {DOERR EE CEECERES PEO
`
`“A reported dissociation constantis valid only for the particular solution conditions under which
`it was measured. Kj values for a protein-ligand interaction can be altered, sometimes by several
`orders of magnitude, by changesin solution salt concentration, pH, or other variables.
`"Interaction of avidin with the enzymatic cofactorbiotin is among the strongest noncovalent
`biochemical interactions known.
`‘This immunoglobulin was isolated as part of an effort to develop a vaccine against HIV.
`Immunoglobulins (described later in the chapter) are highly variable, and the K, reported here
`should not be considered characteristic of all immunoglobulins.
`‘Calmodulin has four binding sites for calcium. The values shown reflect the highest- and
`lowest-affinity binding sites observed in one set of measurements.
`MSN Exhibit 1012 - Part 3 - Page 7 of 24
`MSN Exhibit 1012 - Part 3 - Page 7 of 24
`MSN v. Bausch - IPR2023-00016
`MSNv. Bausch - IPR2023-00016
`
`

`

`Chapter 7 Protein Function
`
`209
`
`The concentration of a volatile substance in solution, however, is always
`proportional to its partial pressure in the gas phase above the solution. In
`experiments using oxygen as a ligand, it is the partial pressure of oxygen,
`pOs, that is varied becausethis is easier to measure than the concentration
`of dissolved oxygen. If we define the partial pressure of oxygen at [Oy]o, as
`Pz», substitution in Equation 7-10 gives
`
`As pO,
`pO, + Pro
`A binding curve for myoglobin that relates @ to pO, is shown in Figure 7—4b.
`
`(7-11)
`
`figure 7-5
`Steric effects on the binding of ligands to the heme of
`myoglobin.
`(a) Oxygen binds to heme with the O, axis at
`an angle, a binding conformation readily accommodated
`by myoglobin. (b) Carbon monoxide binds to free heme
`with the CO axis perpendicular to the plane of the por-
`phyrin ring. CO binding to the heme in myoglobin is
`forced to adopt a slight angle because the perpendicular
`arrangementis sterically blocked by His E7, the distal
`His. This effect weakens the binding of CO to myoglobin.
`(c) Another view showing the arrangement of key amino
`acid residues around the heme of myoglobin. The bound
`Oz is hydrogen-bondedto the distal His, His E7 (His®),
`furtherfacilitating the binding of Oz.
`
`
`
`Protein Structure Affects How Ligands Bind
`The binding of a ligand to a protein is rarely as simple as the above equa-
`tions would suggest. The interaction is greatly affected by protein structure
`and is often accompanied by conformational changes. For example, the
`specificity with which heme binds its various ligands is altered when the
`hemeis a component of myoglobin. CO binds to free heme molecules over
`20,000 times better than does O, (the Ky or Psq for CO binding is more than
`20,000 times lower than that for O,) but binds only about 200 times better
`whenthe hemeis bound in myoglobin. The differenceis partly explained by
`steric hindrance. When O, binds to free heme,the axis of the oxygen mole-
`cule is positioned at an angle to the Fe—O bond (Fig. 7—-5a). In contrast,
`when CO binds to free heme, the Fe, C, and O atomslie in a straight line
`(Fig. 7-5b). In both cases, the binding reflects the geometry of hybrid or-
`bitals in each ligand. In myoglobin, His** (His E7), on the O,-binding side of
`the heme, is too far away to coordinate with the hemeiron, butit does in-
`teract with a ligand bound to heme. This residue, called the distal His, does
`not affect the binding of O. (Fig. 7—-5c) but may precludethe linear binding
`of CO, providing one explanation for the diminished binding of CO to heme
`in myoglobin (and hemoglobin). This effect on CO binding is physiologically
`important, because CO is a low-level byproduct of cellular metabolism.
`Otherfactors, not yet well-defined, also seem to modulate the interaction of
`heme with CO in these proteins.
`The binding of O, to the heme in myoglobin also
`depends on molecular motions, or “breathing,” in the
`protein structure. The heme molecule is deeply
`buried in the folded polypeptide, with no direct path
`for oxygen to go from the surrounding solution to the
`ligand-binding site. If the protein wererigid, O2 could
`not enter or leave the-heme pocket at a measurable
`rate. However, rapid molecular flexing of the amino
`acid side chains produces transient cavities in the
`protein structure, and O, evidently makes its way in
`and out by moving through these cavities. Computer
`simulations of rapid structural fluctuations in myo-
`globin suggest that there are many such pathways.
`One major route is provided by rotation of the side
`chain of the distal His (His™), which occurs on a
`nanosecond (10~* s) time scale. Even subtle confor-
`mational changes can be critical for protein activity.
`
`oO
`O
`#
`Il

`C
`x
`Set Fe —@s
`
`|X
`
`
`
`(ce)
`MSN Exhibit 1012 - Part 3 - Page 8 of 24
`MSN Exhibit 1012 - Part 3 - Page 8 of 24
`MSN v. Bausch - IPR2023-00016
`MSNv. Bausch - IPR2023-00016
`
`

`

`210
`
`Part Il Structure and Catalysis
`
`Oxygen Is Transported in Blood by Hemoglobin
`Nearly all the oxygen carried by whole blood in animals is bound andtrans-
`ported by hemoglobin in erythrocytes (red blood cells). Normal human
`erythrocytes are small (6 to 9 um in diameter), biconcave disks. They are
`formed from precursor stem cells called hemocytoblasts. In the matura-
`tion process, the stem cell produces daughtercells that form large amounts
`of hemoglobin and then lose their intracellular organelles—nucleus, mito-
`chondria, and endoplasmic reticulum. Erythrocytes are thus incomplete,
`vestigial cells, unable to reproduce and, in humans, destined to survive for
`only about 120 days. Their main function is to carry hemoglobin, whichis
`dissolvedin the cytosol at a very high concentration (~34% by weight).
`In arterial blood passing from the lungs through the heart to the pe-
`ripheral tissues, hemoglobin is about 96% saturated with oxygen.In the ve-
`nous blood returning to the heart, hemoglobin is only about 64% saturated.
`Thus, each 100 mL of blood passing through a tissue releases about one-
`third of the oxygenit carries, or 6.5 mL of O, gas at atmospheric pressure
`and body temperature.
`Myoglobin, with its hyperbolic binding curve for oxygen (Fig. 7—4b),
`is relatively insensitive to small changes in the concentration of dissolved
`oxygen and so functions well as an oxygen-storage protein. Hemoglobin,
`with its multiple subunits and O.-bindingsites, is better suited to oxygen
`transport. As we will see, interactions between the subunits of a multimeric
`protein can permit a highly sensitive response to small changesin ligand
`concentration.
`Interactions among the subunits in hemoglobin cause
`conformational changesthatalter the affinity of the protein for oxygen. The
`modulation of oxygen binding allows the O,-transport protein to respond to
`changes in oxygen demandbytissues.
`
`Hemoglobin Subunits Are Structurally Similar to Myoglobin
`Hemoglobin (M, 64,500; abbreviated Hb) is roughly spherical, with a diam-
`eter of nearly 5.5 nm. It is a tetrameric protein containing four heme pros-
`thetic groups, one associated with each polypeptide chain. Adult hemoglo-
`bin contains two types of globin, two a chains (141 residues each) and two
`@ chains (146 residues each). Although fewer than half of the amino acid
`residues in the polypeptide sequencesof the a and B subunits areidentical,
`the three-dimensional structures of the two types of subunits are very sim-
`ilar. Furthermore, their structures are very similar to that of myoglobin
`(Fig. 7-6), even though the amino acid sequencesof the three polypeptides
`are identical at only 27 positions (Fig. 7-7). All three polypeptides are
`
`
`
`Myoglobin
`
`8 subunit of
`hemoglobin
`MSN Exhibit 1012 - Part 3 - Page 9 of 24
`MSN Exhibit 1012 - Part 3 - Page 9 of 24
`MSN v. Bausch - IPR2023-00016
`MSNv. Bausch - IPR2023-00016
`
`figure 7-6
`A comparisonof the structures of myoglobin and the 8
`subunit of hemoglobin.
`
`

`

`Hba Hbg
`F
`F
`K
`R
`100 L
`L
`L
`L
`5
`G
`H
`N
`c
`Vv
`L
`L
`L
`Vv
`Vv
`Cc
`T
`Vv
`
`Mb
`
`LEFIsEAIIHV
`
`v
`
`A
`A
`H
`L
`P
`A
`
`A
`H
`H---
`F
`G
`120K
`
`
`
`E T
`
`CS
`E
`P
`Vv
`Q
`A
`A
`Y
`
`P
`120A
`Vv
`H
`A
`8
`L
`D
`
`v
`
`Q V
`
`
`
`
`
`Distal His E7
`
`
`
`LGAI
`
`L
`T
`N
`A
`Vv
`A
`H
`Vv
`D
`D
`M
`P
`N
`A
`so L
`s
`A
`
`F
`8
`D
`G
`L---
`A
`H
`L
`D
`s80N
`L
`K
`G
`T
`r=
`A
`T
`
`
`
`Ss
`E
`L
`
`E19---L
`
`KKK
`
`80G
`
`HHEAE
`
`FL ---L
`
`KPf
`
`aDe
`
`woeot
`
`G1--100
`
`Proximal His
`
`8
`D
`L
`He
`
`
`Cres
`A
`D
`H
`aR te
`L
`L
`R
`H
`Vv
`Vv
`D
`aes
`P
`100P
`v
`E
`N
`N
`
`
` IZROP|
`
`
`
`KA A
`
`bs:
`
`=O
`
`irco>pd
` Al6---E
`
`SHO>TeOo
`
`A
`Bl --20D
`Vv
`
`AGH
`
`
`
`figure 7-7
`The amino acid sequences of whale myoglobin and the
`a and 8 chains of human hemoglobin. Dashed lines
`mark helix boundaries. To align the sequencesoptimally,
`short breaks must be incorporated into both Hb
`sequences where a few amino acids are present in the
`other sequences. With the exception of the missing D
`helix in Hbe, this alignment permits the use of the helix
`lettering convention that emphasizes the commonposi-
`tioning of amino acid residues that are identicalin all
`three structures (shaded). Residues shaded in red are
`conserved in all known globins. Note that a common
`
`letter-and-number designation for amino acids in two or
`three different structures does not necessarily correspond
`to acommonposition in the linear sequence of amino
`acids in the polypeptides. For example, the distal His
`residue is His E7 in all three structures, but corresponds
`to His, His®®, and His®in the linear sequences of Mb,
`Hba, and Hb§, respectively. Nonhelical residues at the
`amino and carboxyl termini, beyond thefirst (A) and
`last (H) a-helical segments, are labeled NA and HC,
`respectively.
`
`MSN Exhibit 1012 - Part 3 - Page 10 of 24
`MSN Exhibit 1012 - Part 3 - Page 10 of 24
`MSN v. Bausch - IPR2023-00016
`MSNv. Bausch - IPR2023-00016
`
`211
`
`
`
`

`

`212
`
`Part Il
`
`Structure and Catalysis
`
` By
`
`ay
`
`figure 7-8
`Dominantinteractions between hemoglobin subunits.
`In this representation, a subunits are light and 8 subunits
`are dark. The strongest subunit interactions, highlighted,
`occur between unlike subunits. When oxygen binds, the
`a8; contact changeslittle, but there is a large change at
`the a;8> contact, with several ion pairs broken.
`
`members of the globin family of proteins. The helix-naming convention de-
`scribed for myoglobin is also appl

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket